Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) saw a significant increase in short interest in May. As of May 29th, there was short interest totaling 10,333 shares, an increase of 2,061.7% from the May 14th total of 478 shares. Based on an average daily trading volume, of 67,516 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are short sold.
Raia Drogasil Stock Up 2.0%
Raia Drogasil stock traded up $0.07 during trading on Wednesday, reaching $3.50. 537 shares of the company’s stock were exchanged, compared to its average volume of 19,732. The company’s 50-day moving average is $4.21 and its two-hundred day moving average is $4.48. Raia Drogasil has a 52-week low of $2.25 and a 52-week high of $5.34.
Analysts Set New Price Targets
Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Raia Drogasil currently has a consensus rating of “Hold”.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- Nebius Group’s £1.7 Billion UK Expansion Fuels Bullish Case Despite the Pullback
- An Analyst Just Raised Tesla’s Price Target by 227%—Here’s Why
- AST SpaceMobile’s SpaceX Catalyst Could Come With a Volatility Warning
- GameStop’s $2 Billion Buyback Sends a Confusing Signal to Investors
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
